Comparing the effectiveness, safety and tolerability of interventions for depressive symptoms in people with multiple sclerosis: a systematic review and network meta-analysis protocol
Background Comorbid depression is prevalent in people with multiple sclerosis (MS). Depression is commonly untreated or undertreated, thus, there is a need for effective and safe interventions and current guidelines recommend psychological and pharmaceutical interventions for people with MS. However...
Saved in:
Main Authors: | Amalia Karahalios, Allan G Kermode, Yvonne C Learmonth, Julia Lyons, Stephanie Campese, Alexandra Metse, Claudia H Marck |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e055796.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Smoking habits, awareness and support needs for cessation among people with multiple sclerosis in Australia: findings from an online survey
by: Roshan das Nair, et al.
Published: (2022-07-01) -
Corrigendum to “A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis”
by: I. I. Kneebone, et al.
Published: (2020-01-01) -
Can Meditation Influence Quality of Life, Depression, and Disease Outcome in Multiple Sclerosis? Findings from a Large International Web-Based Study
by: Adam B. Levin, et al.
Published: (2014-01-01) -
Moderating effect of social participation on the relationship between health status and depressive symptoms in older adults
by: Yvonne Su Yong Ow, et al.
Published: (2025-02-01) -
Analysis of Benzene-Induced Effects on Rhodococcus sp. 33 Reveals that Constitutive Processes Play a Major Role in Conferring Tolerance
by: Tony Gutiérrez, et al.
Published: (2009-01-01)